FDA Brief

Warning letters Drugs

FDA warning letter to

Ammonia Sport Inc.

High riskIssued Mar 19, 2024Posted Mar 26, 2024Center for Drug Evaluation and Research | CDER

Ammonia Sport Inc. sells three smelling-salt stimulant drugs as unapproved new drugs and misbranded products, FDA says.

What happened

FDA reviewed the company's website in November 2023 and again in March 2024 and found AMMONIA SPORT AQUA, RAW and SQUEEZE offered for sale in the United States. FDA says the labels, website, Facebook and Instagram claims (for example "boost focus, energy, and strength" and "Prevents and Treats Fainting") show the products are intended as drugs. No FDA-approved application is in effect for these products, and they do not meet the conditions of the over-the-counter (OTC) monograph, which is FDA's rulebook for marketing certain nonprescription drugs without approval.

What FDA found

  1. The three products are drugs sold without an FDA-approved application, which makes them unapproved new drugs.

    section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  2. The products are misbranded because they are nonprescription drugs that do not comply with the requirements for marketing under section 505G and have no approved application.

    section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)
  3. Ammonia products labeled as reflex stimulants (smelling salts) were proposed by FDA in 2008 as not generally recognized as safe and effective, so these products needed an approved application starting September 23, 2020.

    section 505G(a)(4) of the FD&C Act, 21 U.S.C. 355h(a)(4)
  4. Even as general stimulants, the products do not match OTC Monograph M011, which allows only caffeine for oral use, because they use other ingredients and give directions for use in the nose.

    OTC Monograph M011; section 505G of the FD&C Act
  5. Label claims such as boosting strength, energy and focus, and preventing and treating fainting, show the products are intended for drug uses.

    21 CFR 201.128
  6. Sending unapproved and misbranded drugs into interstate commerce is prohibited.

    sections 301(d) and 301(a) of the FD&C Act, 21 U.S.C. 331(d) and (a)

What FDA wants

FDA asks the company to write within 15 working days describing the specific steps taken to fix the violations and prevent them from happening again, with supporting documents. If the work cannot be finished in that time, the company must say why and give a completion date.

Who should pay attention

  • online marketplaces and retailers that list ammonia smelling salts
  • brands that private-label or repackage smelling salts
  • sports supplement distributors and team equipment suppliers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk